Chargement en cours...
SCR7, a potent cancer therapeutic agent and a biochemical inhibitor of nonhomologous DNA end‐joining
BACKGROUND: DNA double‐strand breaks (DSBs) are harmful to the cell as it could lead to genomic instability and cell death when left unrepaired. Homologous recombination and nonhomologous end‐joining (NHEJ) are two major DSB repair pathways, responsible for ensuring genome integrity in mammals. Ther...
Enregistré dans:
| Publié dans: | Cancer Rep (Hoboken) |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8222562/ https://ncbi.nlm.nih.gov/pubmed/33496064 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cnr2.1341 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|